FDA approves GERD generic

ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of a gastroesophageal reflux disease drug, FDA records show.

The agency approved Indian drug maker Wockhardt’s ranitidine hydrochloride tablets in the 150-mg and 300-mg strengths, generic versions of GlaxoSmithKline’s Zantac 150 and Zantac 300.

Eleven other generic drug makers manufacture generic versions of Zantac, according to the FDA.